Cargando…

Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and Challenges

The recent advances in immunotherapy and the availability of novel drugs to target the tumor microenvironment have dramatically changed the paradigm of cancer treatment. Nevertheless, a significant proportion of cancer patients are unresponsive or develop resistance to these treatments. With the aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pilla, Lorenzo, Maccalli, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163220/ https://www.ncbi.nlm.nih.gov/pubmed/30004433 http://dx.doi.org/10.3390/biomedicines6030076

Ejemplares similares

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Reverting Immune Suppression to Enhance Cancer Immunotherapy
por: Guerrouahen, Bella S., et al.
Publicado: (2020)

Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy
por: Parmiani, Giorgio, et al.
Publicado: (2015)

Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects
por: Pilla, Lorenzo, et al.
Publicado: (2020)

Recent Advances and Challenges in Cancer Immunotherapy
por: Peterson, Chelsea, et al.
Publicado: (2022)

Update on the challenges and recent advances in cancer immunotherapy
por: Baronzio, Gianfranco, et al.
Publicado: (2013)

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
por: Macpherson, Anne M., et al.
Publicado: (2020)

The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy
por: Ravindran, Shilpa, et al.
Publicado: (2019)

The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
por: Botticelli, Andrea, et al.
Publicado: (2022)

The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
por: Kang, Synat, et al.
Publicado: (2021)

Advances and challenges in immunotherapy of small cell lung cancer
por: Guo, Hanfei, et al.
Publicado: (2020)

A review on the advances and challenges of immunotherapy for head and neck cancer
por: Cheng, Gang, et al.
Publicado: (2021)

Role of Immunotherapy in Gastroesophageal Cancers—Advances, Challenges and Future Strategies
por: Lynch, Emer, et al.
Publicado: (2023)

Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
por: Albarrán-Artahona, Víctor, et al.
Publicado: (2022)

Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs
por: Tomei, Sara, et al.
Publicado: (2021)

Advancements and challenges in treating advanced gastric cancer in the West
por: Leiting, Jennifer L, et al.
Publicado: (2019)

High-dimensional immune-profiling in cancer: implications for immunotherapy
por: Chuah, Samuel, et al.
Publicado: (2020)

Recent Advances and Challenges in Uveal Melanoma Immunotherapy
por: Fu, Yihang, et al.
Publicado: (2022)

Advances and challenges of immunotherapies in NK/T cell lymphomas
por: He, Ling, et al.
Publicado: (2023)

Cancer immunotherapy: recent advances and challenges
por: Swami, Umang, et al.
Publicado: (2021)

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
por: Maalej, Karama Makni, et al.
Publicado: (2023)

Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges
por: Liu, Zhaoyuan, et al.
Publicado: (2021)

Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy
por: Merlano, Marco Carlo, et al.
Publicado: (2021)

CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities
por: Ren, Anqi, et al.
Publicado: (2023)

Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy
por: Aktar, Nasrin, et al.
Publicado: (2022)

Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
por: Rocco, Danilo, et al.
Publicado: (2023)

Immunotherapy in Advanced Biliary Tract Cancers
por: Boilève, Alice, et al.
Publicado: (2021)

Acquired resistance for immune checkpoint inhibitors in cancer immunotherapy: challenges and prospects
por: Chen, Xunrui, et al.
Publicado: (2022)

Translational cancer biology
por: Maccalli, Cristina
Publicado: (2020)

Advances in immunotherapy for treatment of lung cancer
por: Bustamante Alvarez, Jean G., et al.
Publicado: (2015)

Advancements in Cancer Immunotherapies
por: Roy, Ruchi, et al.
Publicado: (2022)

Leishmania Immunity: Advancing Immunotherapy and Vaccine Development
por: Ikeogu, Nnamdi M., et al.
Publicado: (2020)

Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
por: Subhash, Vinod Vijay, et al.
Publicado: (2015)

Metallic Nanoparticle-Mediated Immune Cell Regulation and Advanced Cancer Immunotherapy
por: Mohapatra, Adityanarayan, et al.
Publicado: (2021)

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
por: Wang, Yuchen, et al.
Publicado: (2022)

The early antitumor immune response is necessary for tumor growth: Re-visiting Prehn’s hypothesis in the human melanoma system
por: Parmiani, Giorgio, et al.
Publicado: (2012)

Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy
por: Lauriola, Angela, et al.
Publicado: (2023)

Glioma Immunotherapy: Advances and Challenges for Spinal Cord Gliomas
por: Grady, Clare, et al.
Publicado: (2022)

Immune Evasion as the Main Challenge for Immunotherapy of Cancer
por: Zagozdzon, Radoslaw, et al.
Publicado: (2022)

Novel technologies and emerging biomarkers for personalized cancer immunotherapy
por: Yuan, Jianda, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o7cnv58utvchseceh23410fi00